Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5YPL

Crystal structure of NDM-1 bound to hydrolyzed imipenem representing an EP complex

Summary for 5YPL
Entry DOI10.2210/pdb5ypl/pdb
DescriptorMetallo-beta-lactamase NDM-1, ZINC ION, (2R,4S)-2-[(1S,2R)-1-carboxy-2-hydroxypropyl]-4-[(2-{[(Z)-iminomethyl]amino}ethyl)sulfanyl]-3,4-dihydro-2H-pyrrole-5-ca rboxylic acid, ... (6 entities in total)
Functional Keywordsndm-1, imipenem, ep complex, hydrolase
Biological sourceEscherichia coli
Total number of polymer chains2
Total formula weight52291.51
Authors
Feng, H.,Wang, D.,Liu, W. (deposition date: 2017-11-02, release date: 2018-02-21, Last modification date: 2023-11-22)
Primary citationFeng, H.,Liu, X.,Wang, S.,Fleming, J.,Wang, D.C.,Liu, W.
The mechanism of NDM-1-catalyzed carbapenem hydrolysis is distinct from that of penicillin or cephalosporin hydrolysis.
Nat Commun, 8:2242-2242, 2017
Cited by
PubMed Abstract: New Delhi metallo-β-lactamases (NDMs), the recent additions to metallo-β-lactamases (MBLs), pose a serious public health threat due to its highly efficient hydrolysis of β-lactam antibiotics and rapid worldwide dissemination. The MBL-hydrolyzing mechanism for carbapenems is less studied than that of penicillins and cephalosporins. Here, we report crystal structures of NDM-1 in complex with hydrolyzed imipenem and meropenem, at resolutions of 1.80-2.32 Å, together with NMR spectra monitoring meropenem hydrolysis. Three enzyme-intermediate/product derivatives, EI, EI, and EP, are trapped in these crystals. Our structural data reveal double-bond tautomerization from Δ to Δ, absence of a bridging water molecule and an exclusive β-diastereomeric product, all suggesting that the hydrolytic intermediates are protonated by a bulky water molecule incoming from the β-face. These results strongly suggest a distinct mechanism of NDM-1-catalyzed carbapenem hydrolysis from that of penicillin or cephalosporin hydrolysis, which may provide a novel rationale for design of mechanism-based inhibitors.
PubMed: 29269938
DOI: 10.1038/s41467-017-02339-w
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.8 Å)
Structure validation

246905

PDB entries from 2025-12-31

PDB statisticsPDBj update infoContact PDBjnumon